Change in Management - Onesource Specialty Pharma LimitedNSE · exchange filing · pdf
Source filing Company dossier
Onesource Specialty Pharma
NSE:ONESOURCE · ISIN INE013P01021
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Onesource Specialty Pharma
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Onesource Specialty Pharma LimitedNSE · exchange filing · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Onesource Specialty Pharma LimitedNSE · conference call · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Updates - Onesource Specialty Pharma LimitedNSE · exchange filing · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSBSE · exchange filing · pdf
Source filing Press Release - Onesource Specialty Pharma LimitedNSE · exchange filing · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Change in Management - Onesource Specialty Pharma LimitedNSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Onesource Specialty Pharma LimitedNSE · financial results · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Board Meeting Outcome for Intimation Of The Outcome Of The Board Meeting Dated July 24, 2026, For The Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026BSE · financial results · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Onesource Specialty Pharma LimitedNSE · conference call · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended June 30, 2026.BSE · financial results · pdf
Source filing Updates - Onesource Specialty Pharma LimitedNSE · exchange filing · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Onesource Specialty Pharma And Formycon AG Announce
Strategic Manufacturing Partnership For BiosimilarsBSE · exchange filing · pdf
Source filing Updates - Onesource Specialty Pharma LimitedNSE · exchange filing · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015BSE · exchange filing · pdf
Source filing General Updates - Onesource Specialty Pharma LimitedNSE · exchange filing · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSBSE · exchange filing · pdf
Source filing Updates - Onesource Specialty Pharma LimitedNSE · exchange filing · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Completion Of US-FDA Inspection At Sterile Product Division (SPD) Facility At BengaluruBSE · exchange filing · pdf
Source filing Trading Window - Onesource Specialty Pharma LimitedNSE · exchange filing · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Closure of Trading WindowBSE · financial results · pdf
Source filing Disclosure under SEBI Takeover Regulations - Onesource Specialty Pharma LimitedNSE · exchange filing · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - General- UpdateBSE · exchange filing · pdf
Source filing Updates - Onesource Specialty Pharma LimitedNSE · exchange filing · pdf
Source filing Updates - Onesource Specialty Pharma LimitedNSE · financial results · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Onesource Specialty Pharma LimitedNSE · conference call · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - General-UpdateBSE · exchange filing · pdf
Source filing Updates - Onesource Specialty Pharma LimitedNSE · exchange filing · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Copy of Newspaper Publication - Onesource Specialty Pharma LimitedNSE · financial results · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Onesource Specialty Pharma Ltd - 544292 - Update On Composite Scheme Of AmalgamationBSE · exchange filing · pdf
Source filing